New cancer clinical trial: Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors

Published on: December 29, 2017 at 10:00AM
Conditions:   Central Nervous System Embryonal Tumor, Not Otherwise Specified;   Malignant Glioma;   Recurrent Atypical Teratoid/Rhabdoid Tumor;   Recurrent Childhood Ependymoma;   Recurrent Diffuse Intrinsic Pontine Glioma;   Recurrent Medulloblastoma;   Refractory Diffuse Intrinsic Pontine Glioma
Interventions:   Drug: Everolimus;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Ribociclib
Sponsors:   Pediatric Brain Tumor Consortium;   National Cancer Institute (NCI)
Not yet recruiting
http://ift.tt/2CbXYsr